Clinical trial
Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma
NCT07310745 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma
- Lead sponsor
- Azienda USL Reggio Emilia - IRCCS
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- December 18, 2025
- Completion date
- December 31, 2026
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary indolent cutaneous b-cell lymphoma